tiprankstipranks
Trending News
More News >
Avenue Therapeutics (ATXI)
OTHER OTC:ATXI
US Market

Avenue Therapeutics (ATXI) Income Statement

Compare
331 Followers

Avenue Therapeutics Income Statement

Last quarter (Q3 2025), Avenue Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Avenue Therapeutics's net income was $-683.00K. See Avenue Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.28M$ 14.54M$ 8.04M$ 3.74M$ 5.21M
Depreciation and Amortization
$ 0.00$ 14.54M$ 0.00$ 3.74M$ 0.00
EBITDA
$ -11.70M$ 4.05M$ -2.44M$ 7.00K$ -5.15M
Operating Income
$ -11.28M$ -14.54M$ -8.04M$ -3.74M$ -5.21M
Other Income/Expenses
$ -413.00K$ 4.05M$ 4.44M$ 7.00K$ 62.00K
Pretax Income
$ -11.70M$ -10.49M$ -3.60M$ -3.73M$ -5.15M
Net Income
$ -11.65M$ -10.38M$ -3.55M$ -3.73M$ -5.15M
Per Share Metrics
Basic EPS
$ -0.90$ -73.60$ -121.91$ -3.29$ -4.65
Diluted EPS
$ -0.90$ -73.48$ -121.91$ -3.29$ -4.65
Weighted Average Shares Outstanding
12.95M 141.00K 29.14K 1.13M 1.10M
Weighted Average Shares Outstanding (Diluted)
12.95M 141.22K 29.14K 1.13M 1.10M
Currency in USD

Avenue Therapeutics Earnings and Revenue History